Total investments received (USD): 15.22m
Round value (USD): N/A
Round investors:
Beaumont Capital
Company: IMU Biosciences






Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Portugal
Spain